Ipilimumab 12-month Intensive Pharmacovigilance Protocol

Update Il y a 4 ans
Reference: NCT02050594

Woman and Man

Extract

The primary objective of the protocol is to identify and describe observed adverse events (AEs) while on treatment with Ipilimumab for advanced melanoma in Venezuela during the study period


Inclusion criteria

  • Melanoma

Links